Abstract:Prediction of the stage of cancer plays an important role in planning the course of treatment and has been largely reliant on imaging tools which do not capture molecular events that cause cancer progression. Gene-expression data-based analyses are able to identify these events, allowing RNA-sequence and microarray cancer data to be used for cancer analyses. Breast cancer is the most common cancer worldwide, and is classified into four stages - stages 1, 2, 3, and 4 [2]. While machine learning models have previously been explored to perform stage classification with limited success, multi-class stage classification has not had significant progress. There is a need for improved multi-class classification models, such as by investigating deep learning models. Gene-expression-based cancer data is characterised by the small size of available datasets, class imbalance, and high dimensionality. Class balancing methods must be applied to the dataset. Since all the genes are not necessary for stage prediction, retaining only the necessary genes can improve classification accuracy. The breast cancer samples are to be classified into 4 classes of stages 1 to 4. Invasive ductal carcinoma breast cancer samples are obtained from The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) datasets and combined. Two class balancing techniques are explored, synthetic minority oversampling technique (SMOTE) and SMOTE followed by random undersampling. A hybrid feature selection pipeline is proposed, with three pipelines explored involving combinations of filter and embedded feature selection methods: Pipeline 1 - minimum-redundancy maximum-relevancy (mRMR) and correlation feature selection (CFS), Pipeline 2 - mRMR, mutual information (MI) and CFS, and Pipeline 3 - mRMR and support vector machine-recursive feature elimination (SVM-RFE). The classification is done using deep learning models, namely deep neural network, convolutional neural network, recurrent neural network, a modified deep neural network, and an AutoKeras generated model. Classification performance post class-balancing and various feature selection techniques show marked improvement over classification prior to feature selection. The best multiclass classification was found to be by a deep neural network post SMOTE and random undersampling, and feature selection using mRMR and recursive feature elimination, with a Cohen-Kappa score of 0.303 and a classification accuracy of 53.1%. For binary classification into early and late-stage cancer, the best performance is obtained by a modified deep neural network (DNN) post SMOTE and random undersampling, and feature selection using mRMR and recursive feature elimination, with an accuracy of 81.0% and a Cohen-Kappa score (CKS) of 0.280. This pipeline also showed improved multiclass classification performance on neuroblastoma cancer data, with a best area under the receiver operating characteristic (auROC) curve score of 0.872, as compared to 0.71 obtained in previous work, an improvement of 22.81%. The results and analysis reveal that feature selection techniques play a vital role in gene-expression data-based classification, and the proposed hybrid feature selection pipeline improves classification performance. Multi-class classification is possible using deep learning models, though further improvement particularly in late-stage classification is necessary and should be explored further.

RNA-Seq analysis for breast cancer detection: a study on paired tissue samples using hybrid optimization and deep learning techniques

Analyzing RNA-Seq Gene Expression Data Using Deep Learning Approaches for Cancer Classification

Comparative Study of Cancer Classification by Analysis of RNA-seq Gene Expression Levels

A bio-inspired convolution neural network architecture for automatic breast cancer detection and classification using RNA-Seq gene expression data

Deep learning techniques for cancer classification using microarray gene expression data

Integrative Analysis of RNA Expression Data Unveils Distinct Cancer Types through Machine Learning Techniques

Deep Learning to Analyze RNA-Seq Gene Expression Data

Identification of Gene Expression in Different Stages of Breast Cancer with Machine Learning

hist2RNA: An efficient deep learning architecture to predict gene expression from breast cancer histopathology images

Deep Learning Based Model for Breast Cancer Subtype Classification

Deep-Learning-Based Cancer Profiles Classification Using Gene Expression Data Profile

Deep learning-driven multi-omics sequential diagnosis with Hybrid-OmniSeq: Unraveling breast cancer complexity

RNA-Seq-Based Breast Cancer Subtypes Classification Using Machine Learning Approaches

Identifying and Analyzing Different Cancer Subtypes Using RNA-seq Data of Blood Platelets.

Leveraging Deep Learning Techniques and Integrated Omics Data for Tailored Treatment of Breast Cancer

Enhancing the prediction of IDC breast cancer staging from gene expression profiles using hybrid feature selection methods and deep learning architecture

Enhancing Breast Cancer Prediction through Deep Learning and Comparative Analysis of Gene Expression and DNA Methylation Data using Convolutional Neural Networks

Deep learning-based cancer survival prognosis from RNA-seq data: approaches and evaluations

Machine Learning Analysis of RNA-seq Data for Diagnostic and Prognostic Prediction of Colon Cancer

A semi-supervised deep learning method based on stacked sparse auto-encoder for cancer prediction using RNA-seq data

Optimizing Gene Selection and Cancer Classification with Hybrid Sine Cosine and Cuckoo Search Algorithm